Showing results (351-360 of 414) with videos related to

Sort By:
Pageof 42
The American Journal of Gastroenterology|February 2, 2023
Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment TrialJordan J Feld, Abdus S Wahed, Michael Fried, et al.
Circulation Research|September 1, 1996
Cloning and characterization of rat density-enhanced phosphatase-1, a protein tyrosine phosphatase expressed by vascular cellsL G Borges, R A Seifert, F J Grant, et al.
Gastroenterology|October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinomaAnna S Lok, Richard K Sterling, James E Everhart, et al.
Hepatology (Baltimore, Md.)|July 24, 2012
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantationGregory T Everson, Norah A Terrault, Anna S Lok, et al.
Hepatology (Baltimore, Md.)|December 15, 2018
Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus InfectionJordan J Feld, Norah A Terrault, Hsing-Hua S Lin, et al.
Gastroenterology|November 7, 2007
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis BRobert G Gish, Anna S Lok, Ting-Tsung Chang, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapyD M Evon, J Amador, P Stewart, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2005
Liver transplantation for erythropoietic protoporphyria liver diseaseBrendan M McGuire, Herbert L Bonkovsky, Robert L Carithers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 29, 2021
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH StudyMary J Thomson, Marina Serper, Vandana Khungar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 12, 2019
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV InfectionMayur Brahmania, Manuel Lombardero, Bettina E Hansen, et al.
Pageof 42